Lee, Danner & Bass’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-23,120
Closed -$2.3M 184
2019
Q3
$2.3M Buy
23,120
+200
+0.9% +$19K 0.25% 83
2019
Q2
$2.12M Sell
22,920
-1,803
-7% -$171K 0.22% 87
2019
Q1
$2.33M Buy
24,723
+5,843
+31% +$511K 0.26% 76
2018
Q4
$1.21M Buy
18,880
+490
+3% +$36.2K 0.14% 104
2018
Q3
$1.65M Sell
18,390
-1,738
-9% -$154K 0.16% 97
2018
Q2
$1.6M Buy
20,128
+4,780
+31% +$397K 0.17% 97
2018
Q1
$1.37M Buy
15,348
+4,597
+43% +$441K 0.14% 105
2017
Q4
$1.12M Buy
10,751
+5,518
+105% +$623K 0.11% 109
2017
Q3
$763K Sell
5,233
-70
-1% -$9.54K 0.08% 117
2017
Q2
$689K Buy
5,303
+84
+2% +$10.3K 0.08% 119
2017
Q1
$649K Sell
5,219
-240
-4% -$28.7K 0.07% 118
2016
Q4
$632K Sell
5,459
-25
-0.5% -$2.78K 0.07% 117
2016
Q3
$573K Sell
5,484
-950
-15% -$103K 0.07% 116
2016
Q2
$635K Sell
6,434
-492
-7% -$50.9K 0.08% 115
2016
Q1
$745K Sell
6,926
-1,724
-20% -$178K 0.09% 109
2015
Q4
$1.04M Buy
8,650
+6,000
+226% +$694K 0.14% 98
2015
Q3
$287K Buy
2,650
+20
+0.8% +$2.48K 0.04% 144
2015
Q2
$304K Sell
2,630
-200
-7% -$22.9K 0.04% 145
2015
Q1
$326K Buy
2,830
+22
+0.8% +$2.63K 0.04% 140
2014
Q4
$314K Buy
2,808
+70
+3% +$7.38K 0.04% 139
2014
Q3
$260K Sell
2,738
-8
-0.3% -$722 0.03% 144
2014
Q2
$236K Sell
2,746
-384
-12% -$29.2K 0.03% 147
2014
Q1
$218K Buy
+3,130
New +$248K 0.03% 148

Other funds holding CELG

Lee, Danner & Bass's CELG Position: Q4 2019 in Review

Lee, Danner & Bass sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 23,120 shares — an estimated $2.3M sold.

Lee, Danner & Bass first reported a position in CELG in Q1 2014 and held it in 23 quarters. The position peaked at $2.33M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Lee, Danner & Bass reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Lee, Danner & Bass sold 23,120 Celgene Corp shares in Q4 2019, an estimated $2.3M.
  • Lee, Danner & Bass first reported a position in Celgene Corp in Q1 2014 and held it in 23 quarters.
  • Lee, Danner & Bass's Celgene Corp position peaked at $2.33M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Lee, Danner & Bass's 13F filing for Q4 2019, filed 13 Feb 2020.